Fundraising Fox

Lenoss Medical

Providence, US · 4 known investors

lenoss.com ↗

Lenoss Medical develops the OsteoPearl VBA system, a biological solution for repairing osteoporotic vertebral compression fractures by delivering clinically proven biological tissue instead of traditional bone cement. The device targets patients with spinal fractures and is intended for use by spine surgeons treating vertebral compression fractures.

BiotechHealthtechMedical Devices

Founders & leadership

DM
Dominique MesserliExecutive Officer, Director

Investors · 4

AZ Venture Capital Inc.Phoenix
Beacon AngelsBoston · $50K – $400K
Slater Technology FundProvidence
Walnut Venture AssociatesWellesley

Reported raises · per SEC filings

Form D private placements
▶$1.3MraisedMar 2021 · 32 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dominique MesserliExecutive Officer, Director
Offering amount
$1.4M
Amount sold
$1.3M
First sale
Feb 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.